Award

Laboratory Managed Serivce

UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST

This public procurement record has 1 release in its history.

Award

09 Dec 2022 at 16:36

Summary of the contracting process

The University Hospitals Birmingham NHS Foundation Trust has awarded a contract for a Laboratory Managed Service to Abbott Laboratories Limited. The procurement process was completed and the contract is currently active. This contract involves the installation and commissioning of biomedical equipment, along with training, maintenance, and consumables supply. The procurement method was limited, with the procurement being negotiated without publication of a contract notice.

This tender presents an opportunity for businesses involved in providing installation services of laboratory equipment to compete. Companies experienced in managing comprehensive laboratory services that support clinical outcomes and streamline clinical pathways would be well-suited to compete. The contract value is £41,000,000 GBP, signed on December 8, 2022. The location of the service delivery is in the UK. This opportunity can benefit businesses that specialise in biomedical equipment and laboratory services, particularly those with expertise in managing third-party involvement and overseeing service availability.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Laboratory Managed Serivce

Notice Description

Laboratory Managed Service

Lot Information

Lot 1

A Laboratory Managed Service Contract which will include equipment installation and commissioning and the supply of training, maintenance, consumables and service availability; along with the management of any third party involvement. The Supplier will provide a comprehensive managed service that will act as an enabler for the delivery of clinical services, improve outcomes and support the streamlining of clinical pathways.

Procurement Information

University Hospitals Birmingham NHS Trust (UHB) intends to enter into a new contract with Abbott Laboratories Limited. The main benefit of entering into this contract revolves around the stability of application platforms while service consolidation takes place over the networks. As stated in the NHSE state of the nation document; "Consolidating pathology services allows for most consistent, clinically appropriate turnaround times ensuring the right test is available at the right time... consolidation can ensure an appropriate critical mass to support specialist diagnostics, so that patients have equal access to key tests and services are sustainable" As the capacity for change in the system is currently limited by post-Covid recovery plans, increased Emergency Department activity and other important projects for future productivity and performance (i.e. the current implantation of a new LIMS) a change of supplier will endanger the successful delivery of all of these important projects. Aligned to this a change of major analytical platform - however well planned - will always likely result is a reduction in productivity and consequently the restoration and recovery plan will be severely affected as will current ED turnaround times. It is assessed that the patients of Birmingham and Solihull will be put at a significant disadvantage if a fundamental piece of the diagnostic process undergoes change at this moment in time. Future projects will be enabled and better served by not embarking on a period of change, particularly with reference to a wider BSOL ICS consolidation - including Birmingham Women's and Children's Hospital. In addition, with the implementation of the LIMS across BSOL, in future we will have a digital environment which is standardised and working in all providers of laboratory services in Birmingham and Solihull, reducing the risks of making an analytical transition for the trusts and the suppliers.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-038c67
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/034983-2022
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Negotiated without publication of a contract notice
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

38 - Laboratory, optical and precision equipments (excl. glasses)

51 - Installation services (except software)


CPV Codes

38434540 - Biomedical equipment

51430000 - Installation services of laboratory equipment

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£41,000,000 £10M-£100M

Notice Dates

Publication Date
9 Dec 20223 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
8 Dec 20223 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST
Contact Name
Not specified
Contact Email
daniel.o'sullivan@uhb.nhs.uk
Contact Phone
+44 1213712000

Buyer Location

Locality
BIRMINGHAM
Postcode
B15 2WB
Post Town
Birmingham
Country
England

Major Region (ITL 1)
TLG West Midlands (England)
Basic Region (ITL 2)
TLG3 West Midlands
Small Region (ITL 3)
TLG31 Birmingham
Delivery Location
TLG West Midlands (England)

Local Authority
Birmingham
Electoral Ward
Edgbaston
Westminster Constituency
Birmingham Edgbaston

Supplier Information

Number of Suppliers
1
Supplier Name

ABBOTT LABORATORIES

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-038c67-2022-12-09T16:36:19Z",
    "date": "2022-12-09T16:36:19Z",
    "ocid": "ocds-h6vhtk-038c67",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-038c67",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Laboratory Managed Serivce",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "38434540",
            "description": "Biomedical equipment"
        },
        "mainProcurementCategory": "goods",
        "description": "Laboratory Managed Service",
        "lots": [
            {
                "id": "1",
                "description": "A Laboratory Managed Service Contract which will include equipment installation and commissioning and the supply of training, maintenance, consumables and service availability; along with the management of any third party involvement. The Supplier will provide a comprehensive managed service that will act as an enabler for the delivery of clinical services, improve outcomes and support the streamlining of clinical pathways.",
                "hasOptions": false
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "51430000",
                        "description": "Installation services of laboratory equipment"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKG"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Negotiated without publication of a contract notice",
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_MANUF_FOR_RESEARCH",
                "description": "The products involved are manufactured purely for the purpose of research, experiment, study or development under the conditions stated in the directive"
            },
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_TECHNICAL",
                "description": "The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons"
            }
        ],
        "procurementMethodRationale": "University Hospitals Birmingham NHS Trust (UHB) intends to enter into a new contract with Abbott Laboratories Limited. The main benefit of entering into this contract revolves around the stability of application platforms while service consolidation takes place over the networks. As stated in the NHSE state of the nation document; \"Consolidating pathology services allows for most consistent, clinically appropriate turnaround times ensuring the right test is available at the right time... consolidation can ensure an appropriate critical mass to support specialist diagnostics, so that patients have equal access to key tests and services are sustainable\" As the capacity for change in the system is currently limited by post-Covid recovery plans, increased Emergency Department activity and other important projects for future productivity and performance (i.e. the current implantation of a new LIMS) a change of supplier will endanger the successful delivery of all of these important projects. Aligned to this a change of major analytical platform - however well planned - will always likely result is a reduction in productivity and consequently the restoration and recovery plan will be severely affected as will current ED turnaround times. It is assessed that the patients of Birmingham and Solihull will be put at a significant disadvantage if a fundamental piece of the diagnostic process undergoes change at this moment in time. Future projects will be enabled and better served by not embarking on a period of change, particularly with reference to a wider BSOL ICS consolidation - including Birmingham Women's and Children's Hospital. In addition, with the implementation of the LIMS across BSOL, in future we will have a digital environment which is standardised and working in all providers of laboratory services in Birmingham and Solihull, reducing the risks of making an analytical transition for the trusts and the suppliers."
    },
    "awards": [
        {
            "id": "034983-2022-1-1",
            "relatedLots": [
                "1"
            ],
            "title": "Laboratory Managed Service",
            "status": "active",
            "hasSubcontracting": true,
            "suppliers": [
                {
                    "id": "GB-FTS-70485",
                    "name": "Abbott Laboratories Limited"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-154",
            "name": "University Hospitals Birmingham NHS Foundation Trust",
            "identifier": {
                "legalName": "University Hospitals Birmingham NHS Foundation Trust"
            },
            "address": {
                "streetAddress": "Mindelsohn Way",
                "locality": "Birmingham",
                "region": "UKG3",
                "postalCode": "B15 2WB",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "telephone": "+44 1213712000",
                "email": "daniel.o'sullivan@uhb.nhs.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.uhb.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-70485",
            "name": "Abbott Laboratories Limited",
            "identifier": {
                "legalName": "Abbott Laboratories Limited",
                "id": "00329102"
            },
            "address": {
                "streetAddress": "Abbott House Vanwall Business Park, Vanwall Road,",
                "locality": "Maidenhead",
                "region": "UKJ",
                "postalCode": "SL6 4XE",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-70486",
            "name": "Royal Courts of Justice",
            "identifier": {
                "legalName": "Royal Courts of Justice"
            },
            "address": {
                "streetAddress": "Strand",
                "locality": "London",
                "postalCode": "WC2A",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-154",
        "name": "University Hospitals Birmingham NHS Foundation Trust"
    },
    "contracts": [
        {
            "id": "034983-2022-1-1",
            "awardID": "034983-2022-1-1",
            "title": "Laboratory Managed Service",
            "status": "active",
            "value": {
                "amount": 41000000,
                "currency": "GBP"
            },
            "dateSigned": "2022-12-08T00:00:00Z"
        }
    ],
    "language": "en"
}